Improving Difficult-to-Treat Asthma With Digital Inhaler Adherence Technologies: Are We There Yet?

J Allergy Clin Immunol Pract. 2023 Oct;11(10):3074-3075. doi: 10.1016/j.jaip.2023.08.001.

Authors

Lourdes G Ramirez¹, Ann Chen Wu²

Affiliations

¹ Division of Allergy and Clinical Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass. Electronic address: lgramirez@bwh.harvard.edu.
² Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Mass.

PMID: 37805222
DOI: 10.1016/j.jaip.2023.08.001

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Administration, Inhalation
Asthma* / drug therapy
Humans
Medication Adherence
Nebulizers and Vaporizers

Grants and funding

T32 HL007427/HL/NHLBI NIH HHS/United States